|
Research Advisory Panel
California requires proposed research projects involving certain opioid, stimulant, and hallucinogenic drugs classified as Schedule I and Schedule II controlled substances to be
pre-reviewed and authorized by the Research Advisory Panel of California in the Attorney General's Office.
Researchers must submit applications to the panel for research projects involving:
- Any Schedule I controlled substance;
- Human research using any Schedule I or Schedule II controlled substance; or
- Research for the treatment of drug abuse using any drug, scheduled or not.
The Research Advisory Panel of California primarily seeks to ensure the safety and protection of participating human research subjects and adequate security of the controlled substances used in the study. The Panel members evaluate the scientific validity of each proposed project, and may reject proposals where the research is poorly conceived, would produce conclusions of little scientific value, or would not justify the exposure of California subjects to the risk of the research.
During 2003, the Panel reviewed 50 new research study submissions. Thirty-nine of the reviews were for human studies and 11 were for animal or laboratory studies. A total of 44 new research studies and seven revisions were approved. At the end of 2003, the Panel was monitoring 136 research projects.
Applicants may contact the Panel Office or the Drug Enforcement Administration for the most recent Controlled Substance Schedules.
|
